November 10-15

The official news source of

ACR Convergence 2023

San Diego, CA

Home // SSc-ILD: When Systemic Sclerosis Affects the Lung

SSc-ILD: When Systemic Sclerosis Affects the Lung


1 minute

Friday, November 6, 2020 | 2:00 PM EST
Supported by Boehringer Ingelheim Pharmaceuticals, Inc.


Primary Session Topic:
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)

Session Description:
Join expert rheumatologist Joy Schechtman as she provides an overview of systemic sclerosis-associated interstitial lung disease (SSc-ILD), highlighting the common signs and symptoms and difficulties in the recognition and diagnosis of the disease, and the significance of fibrosis in these patients. Dr Schechtman is the head of Sun Valley Arthritis Center, Ltd. She is board certified in Rheumatology and a Fellow of the American College of Rheumatologists. She is an Associate Professor with Midwestern University and former Chief of Staff of Arrowhead Hospital.

This program is developed and offered by Boehringer Ingelheim. This is not an official program of the American College of Rheumatology.

Session Speaker:
Joy Schechtman, DO, FACR, FACOI